April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...
For many years, the manufacturer of Fosamax did not inform patients of a known, important adverse reaction to their drug: an atypical femoral fracture (AFF). The thigh bone (femur) can break ...
LOS ANGELES, May 28 (Reuters) - Amgen Inc said on Wednesday its experimental osteoporosis drug denosumab achieved greater bone density than Merck & Co Inc's Fosamax, but some analysts expressed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results